← Leaderboards
Shelly McQuone
University Of Pennsylvania
$248,292
Attributed
$248,292
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$248,292 · 1
By mechanism
M01$248,292 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- James M Wilson$22,532,723
- Rob R Macgregor$4,980,820
- Ian Frank$25,757,892
- Serge Y Fuchs$17,647,204
- Harvey Michael Friedman$28,257,678
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical Trial Phase IGene ExpressionGene TherapyHead /Neck NeoplasmHuman SubjectHuman Therapy EvaluationInterferon AlphaInterleukin 12Neoplasm /Cancer ImmunotherapySquamous Cell Carcinoma
Grant awards (6)
INF ALPHA GENE THERAPY IN PTS W SQUAMOUS CELL CARCINOMA OF HEAD AND NECK$124,146
M01 · FY2002 · RR
INF ALPHA GENE THERAPY IN PTS W SQUAMOUS CELL CARCINOMA OF HEAD AND NECK$124,146
M01 · FY2001 · RR
INF ALPHA GENE THERAPY IN PTS W SQUAMOUS CELL CARCINOMA OF HEAD AND NECK$0
M01 · FY2001 · RR
INF ALPHA GENE THERAPY IN PTS W SQUAMOUS CELL CARCINOMA OF HEAD AND NECK$0
M01 · FY2000 · RR
INF ALPHA GENE THERAPY IN PTS W SQUAMOUS CELL CARCINOMA OF HEAD AND NECK$0
M01 · FY2000 · RR
INF ALPHA GENE THERAPY IN PTS W SQUAMOUS CELL CARCINOMA OF HEAD AND NECK$0
M01 · FY2000 · RR